ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
-0,01%
Bitcoin
67.716,00
0,35%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Frequency Therapeutics Inc (FREQ)

  7. Frequency Therapeutics Inc (FREQ) News

FREQ

Frequency Therapeutics (FREQ)

Frequency Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FREQ
DatumZeitQuelleÜberschriftSymbolFirma
01/05/202423h18Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FREQFrequency Therapeutics Inc
29/04/202413h47Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:FREQFrequency Therapeutics Inc
29/04/202413h44Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FREQFrequency Therapeutics Inc
29/04/202413h42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
26/04/202422h01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FREQFrequency Therapeutics Inc
25/04/202401h33Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
24/04/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
24/04/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
24/04/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
23/04/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
22/04/202423h14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
22/04/202423h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
19/04/202422h06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
18/04/202414h52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
18/04/202414h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
28/03/202420h20Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
28/03/202405h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FREQFrequency Therapeutics Inc
26/03/202422h09Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FREQFrequency Therapeutics Inc
26/03/202422h03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FREQFrequency Therapeutics Inc
26/03/202421h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
26/03/202421h02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FREQFrequency Therapeutics Inc
06/11/202323h24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FREQFrequency Therapeutics Inc
06/11/202323h22Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FREQFrequency Therapeutics Inc
06/11/202314h51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
02/11/202321h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FREQFrequency Therapeutics Inc
25/10/202322h01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FREQFrequency Therapeutics Inc
12/10/202322h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FREQFrequency Therapeutics Inc
02/10/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FREQFrequency Therapeutics Inc
29/09/202322h14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
28/09/202312h06Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FREQ

Kürzlich von Ihnen besucht

ASX
WBCLOR
LSE
BG27
Newday Fmi 26 A
NYSE
HYH.CL
COIN
GOLEUR
COIN
LEMOUST
Lemo
BIT
UB87N4
Unicredit Bank
BIT
ESOY
ETFS EUR Daily Hedged So...
TSXV
JCI.P
TG
9S70
Critical Resources
LSE
48AI
Hsbc Bk. 28
LBNK
MOONRISEUSDT
MoonRise
NASDAQ
FJEAZX
Senior Loan and Limited ...
USOTC
RRYES
RSE Archive (GM)
ASX
ANZLOU
NYSE
SHLD
Global X Funds
IDCM
CONSTBTC
Constant
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten